ETF Managers Group’s GSK GSK Stock Holding History

ETF Managers Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$142K	Buy	+3,992	New	+$140K	﹤0.01%	615
2022 Q4	–	Sell	-5,570	Closed	-$164K	–	589
2022 Q3	$164K	Buy	5,570 +2,236	+67%	+$84.7K	0.01%	620
2022 Q2	$182K	Sell	3,334 -1,208	-27%	-$66.7K	0.01%	652
2022 Q1	$248K	Sell	4,542 -2,780	-38%	-$151K	0.01%	588
2021 Q4	$404K	Sell	7,322 -2,384	-25%	-$124K	0.01%	552
2021 Q3	$465K	Buy	9,706 +2,264	+30%	+$114K	0.01%	543
2021 Q2	$372K	Sell	7,442 -1,013	-12%	-$48.7K	0.01%	570
2021 Q1	$384K	Buy	8,455 +406	+5%	+$18.4K	0.01%	543
2020 Q4	$373K	Buy	8,049 +887	+12%	+$40.7K	0.01%	478
2020 Q3	$335K	Buy	7,162 +4,594	+179%	+$230K	0.01%	415
2020 Q2	$131K	Buy	+2,568	New	+$132K	﹤0.01%	575

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return